These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 18991629)

  • 21. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
    Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
    Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.
    Chiu PF; Lin IC; Lu YL; Chang CN; Chan HY; Lin TS; Tsai KC; Hsieh YSY; Chen MJ; Lin MH; Liang PH
    Bioorg Chem; 2023 Sep; 138():106581. PubMed ID: 37172437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review on Anti-urease Potential of Coumarins.
    Asghar H; Asghar H; Asghar T
    Curr Drug Targets; 2021; 22(17):1926-1943. PubMed ID: 33618646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in the Chemistry of Naturally Occurring Coumarins.
    Sarker SD; Nahar L
    Prog Chem Org Nat Prod; 2017; 106():241-304. PubMed ID: 28762091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
    Howell A; Howell SJ; Clarke R; Anderson E
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J; Singla R; Kumar M; Jaitak V
    Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
    Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
    Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coumarin: a promising scaffold for anticancer agents.
    Kaur M; Kohli S; Sandhu S; Bansal Y; Bansal G
    Anticancer Agents Med Chem; 2015; 15(8):1032-48. PubMed ID: 25553437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents.
    Shaik BB; Katari NK; Seboletswe P; Gundla R; Kushwaha ND; Kumar V; Singh P; Karpoormath R; Bala MD
    Anticancer Agents Med Chem; 2023; 23(2):142-163. PubMed ID: 35440315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
    Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
    Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress in biosynthesis-related enzymes of coumarin compounds and their bioactivities].
    Lyu HW; Liang HM; Zhu MD; Wang H; Li XN
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3693-3705. PubMed ID: 39099344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
    Woo LW; Purohit A; Reed MJ; Potter BV
    J Med Chem; 1996 Mar; 39(7):1349-51. PubMed ID: 8691463
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
    Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Steroid sulfatase inhibitor].
    Nakata T; Ishida H; Shiotsu Y
    Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer Potential of Coumarin and its Derivatives.
    Bhattarai N; Kumbhar AA; Pokharel YR; Yadav PN
    Mini Rev Med Chem; 2021; 21(19):2996-3029. PubMed ID: 33820507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
    Li Y; Tang Q; Xie Y; He D; Yang K; Zheng L
    Bioorg Med Chem Lett; 2021 Feb; 33():127750. PubMed ID: 33340662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid sulphatase inhibitors for breast cancer therapy.
    Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coumarins: old compounds with novel promising therapeutic perspectives.
    Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
    Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review.
    Fotopoulos I; Hadjipavlou-Litina D
    Med Chem; 2020; 16(3):272-306. PubMed ID: 31038071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
    Mamatha SV; Belagali SL; Bhat M; Kumbar VM
    Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.